Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following investor conferences in October and November 2019.


Conference details:

Investir Day 1st Edition
Date:                     Thursday, October 3, 2019
Presentation time:  12:45 p.m. CEDT
Location:                Paris, France
 
CF&B Communication European Large & Midcap Event 19th Edition
Date:                     October 14-15, 2019
Location:                Paris, France
 
Bryan, Garnier & Co European Healthcare Conference
Date:                     Wednesday, November 13, 2019
Location:                Paris, France
 
Finance Avenue 2019
Date:                     Saturday, November 16, 2019
Presentation Time:  12:55 p.m. CEDT
Location:                Brussels, Belgium
 
Jefferies 2019 London Healthcare Conference
Date:                      November 20 - 21, 2019
Location:                 London, United Kingdom

Download press release(s)

Press release

61.84 Ko

Communiqué de presse

84.71 Ko